nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—CYP2C8—Acetylsalicylic acid—Kawasaki disease	0.146	0.311	CbGbCtD
Sorafenib—CYP2C19—Acetylsalicylic acid—Kawasaki disease	0.122	0.261	CbGbCtD
Sorafenib—CYP2C9—Acetylsalicylic acid—Kawasaki disease	0.102	0.217	CbGbCtD
Sorafenib—ABCB1—Acetylsalicylic acid—Kawasaki disease	0.0987	0.211	CbGbCtD
Sorafenib—FLT1—umbilical vein—Kawasaki disease	0.0124	0.0401	CbGeAlD
Sorafenib—CDKL3—heart—Kawasaki disease	0.0105	0.0339	CbGeAlD
Sorafenib—KDR—umbilical vein—Kawasaki disease	0.0105	0.0339	CbGeAlD
Sorafenib—TIE1—endothelium—Kawasaki disease	0.00914	0.0296	CbGeAlD
Sorafenib—FLT4—endothelium—Kawasaki disease	0.00756	0.0244	CbGeAlD
Sorafenib—FLT1—artery—Kawasaki disease	0.00695	0.0225	CbGeAlD
Sorafenib—HIPK3—cardiac ventricle—Kawasaki disease	0.0065	0.021	CbGeAlD
Sorafenib—HIPK3—myocardium—Kawasaki disease	0.00611	0.0198	CbGeAlD
Sorafenib—KDR—artery—Kawasaki disease	0.00588	0.019	CbGeAlD
Sorafenib—FLT1—endothelium—Kawasaki disease	0.00587	0.019	CbGeAlD
Sorafenib—TIE1—myocardium—Kawasaki disease	0.00571	0.0185	CbGeAlD
Sorafenib—MAPK11—heart—Kawasaki disease	0.00513	0.0166	CbGeAlD
Sorafenib—CDK7—heart—Kawasaki disease	0.00504	0.0163	CbGeAlD
Sorafenib—TAOK2—heart—Kawasaki disease	0.005	0.0162	CbGeAlD
Sorafenib—KDR—endothelium—Kawasaki disease	0.00497	0.0161	CbGeAlD
Sorafenib—AURKC—heart—Kawasaki disease	0.00496	0.016	CbGeAlD
Sorafenib—PDGFRA—gall bladder—Kawasaki disease	0.00478	0.0154	CbGeAlD
Sorafenib—MAP3K7—cardiac ventricle—Kawasaki disease	0.00469	0.0151	CbGeAlD
Sorafenib—FGFR1—myocardium—Kawasaki disease	0.00466	0.015	CbGeAlD
Sorafenib—MKNK2—cardiac ventricle—Kawasaki disease	0.00454	0.0147	CbGeAlD
Sorafenib—MKNK1—cardiac ventricle—Kawasaki disease	0.00448	0.0145	CbGeAlD
Sorafenib—MAP3K7—myocardium—Kawasaki disease	0.00441	0.0142	CbGeAlD
Sorafenib—KIT—endothelium—Kawasaki disease	0.0044	0.0142	CbGeAlD
Sorafenib—RET—neck—Kawasaki disease	0.0044	0.0142	CbGeAlD
Sorafenib—ZAK—heart—Kawasaki disease	0.00436	0.0141	CbGeAlD
Sorafenib—MKNK2—myocardium—Kawasaki disease	0.00427	0.0138	CbGeAlD
Sorafenib—HIPK3—heart—Kawasaki disease	0.00427	0.0138	CbGeAlD
Sorafenib—MKNK1—myocardium—Kawasaki disease	0.00422	0.0136	CbGeAlD
Sorafenib—RALBP1—cardiac ventricle—Kawasaki disease	0.0041	0.0133	CbGeAlD
Sorafenib—TIE1—heart—Kawasaki disease	0.00399	0.0129	CbGeAlD
Sorafenib—FLT1—cardiac ventricle—Kawasaki disease	0.0039	0.0126	CbGeAlD
Sorafenib—RAF1—cardiac ventricle—Kawasaki disease	0.00388	0.0125	CbGeAlD
Sorafenib—FLT1—neck—Kawasaki disease	0.00388	0.0125	CbGeAlD
Sorafenib—RALBP1—myocardium—Kawasaki disease	0.00386	0.0125	CbGeAlD
Sorafenib—RAF1—neck—Kawasaki disease	0.00385	0.0125	CbGeAlD
Sorafenib—BRAF—heart—Kawasaki disease	0.00382	0.0124	CbGeAlD
Sorafenib—KIT—gall bladder—Kawasaki disease	0.00382	0.0123	CbGeAlD
Sorafenib—PDGFRB—gall bladder—Kawasaki disease	0.00373	0.0121	CbGeAlD
Sorafenib—FLT1—myocardium—Kawasaki disease	0.00367	0.0119	CbGeAlD
Sorafenib—EPHX2—heart—Kawasaki disease	0.00365	0.0118	CbGeAlD
Sorafenib—RAF1—myocardium—Kawasaki disease	0.00365	0.0118	CbGeAlD
Sorafenib—FLT3—heart—Kawasaki disease	0.00363	0.0117	CbGeAlD
Sorafenib—KDR—cardiac ventricle—Kawasaki disease	0.0033	0.0107	CbGeAlD
Sorafenib—FLT4—heart—Kawasaki disease	0.00329	0.0106	CbGeAlD
Sorafenib—KDR—neck—Kawasaki disease	0.00328	0.0106	CbGeAlD
Sorafenib—FGFR1—heart—Kawasaki disease	0.00325	0.0105	CbGeAlD
Sorafenib—MAP2K5—myocardium—Kawasaki disease	0.0031	0.01	CbGeAlD
Sorafenib—KDR—myocardium—Kawasaki disease	0.0031	0.01	CbGeAlD
Sorafenib—MAP3K7—heart—Kawasaki disease	0.00308	0.00994	CbGeAlD
Sorafenib—MKNK2—heart—Kawasaki disease	0.00298	0.00964	CbGeAlD
Sorafenib—MKNK1—heart—Kawasaki disease	0.00294	0.00952	CbGeAlD
Sorafenib—RET—heart—Kawasaki disease	0.00291	0.0094	CbGeAlD
Sorafenib—KIT—neck—Kawasaki disease	0.0029	0.00938	CbGeAlD
Sorafenib—PDGFRB—cardiac ventricle—Kawasaki disease	0.00285	0.00923	CbGeAlD
Sorafenib—PDGFRB—neck—Kawasaki disease	0.00284	0.00917	CbGeAlD
Sorafenib—KIT—myocardium—Kawasaki disease	0.00275	0.00889	CbGeAlD
Sorafenib—RALBP1—heart—Kawasaki disease	0.00269	0.0087	CbGeAlD
Sorafenib—PDGFRB—myocardium—Kawasaki disease	0.00268	0.00868	CbGeAlD
Sorafenib—FLT1—heart—Kawasaki disease	0.00256	0.00828	CbGeAlD
Sorafenib—RAF1—heart—Kawasaki disease	0.00255	0.00823	CbGeAlD
Sorafenib—EPHB6—heart—Kawasaki disease	0.00253	0.00818	CbGeAlD
Sorafenib—RAF1—skin of body—Kawasaki disease	0.00249	0.00806	CbGeAlD
Sorafenib—EPHB6—skin of body—Kawasaki disease	0.00248	0.00801	CbGeAlD
Sorafenib—STK10—heart—Kawasaki disease	0.00242	0.00784	CbGeAlD
Sorafenib—PDGFRA—heart—Kawasaki disease	0.0024	0.00776	CbGeAlD
Sorafenib—MAP2K5—heart—Kawasaki disease	0.00217	0.007	CbGeAlD
Sorafenib—KDR—heart—Kawasaki disease	0.00217	0.007	CbGeAlD
Sorafenib—CSF1R—heart—Kawasaki disease	0.00211	0.00683	CbGeAlD
Sorafenib—CSF1R—skin of body—Kawasaki disease	0.00207	0.00669	CbGeAlD
Sorafenib—KIT—heart—Kawasaki disease	0.00192	0.0062	CbGeAlD
Sorafenib—KIT—skin of body—Kawasaki disease	0.00188	0.00607	CbGeAlD
Sorafenib—PDGFRB—heart—Kawasaki disease	0.00187	0.00606	CbGeAlD
Sorafenib—PDGFRB—skin of body—Kawasaki disease	0.00184	0.00593	CbGeAlD
Sorafenib—ABCC4—heart—Kawasaki disease	0.00149	0.00482	CbGeAlD
Sorafenib—HTR2B—heart—Kawasaki disease	0.00148	0.0048	CbGeAlD
Sorafenib—HTR2B—skin of body—Kawasaki disease	0.00145	0.0047	CbGeAlD
Sorafenib—ABCG2—heart—Kawasaki disease	0.00105	0.0034	CbGeAlD
Sorafenib—CYP2B6—heart—Kawasaki disease	0.000972	0.00314	CbGeAlD
Sorafenib—CYP2C9—heart—Kawasaki disease	0.000962	0.00311	CbGeAlD
Sorafenib—CYP2B6—skin of body—Kawasaki disease	0.000952	0.00308	CbGeAlD
Sorafenib—FLT1—Signaling by VEGF—VEGFA—Kawasaki disease	0.000549	0.00247	CbGpPWpGaD
Sorafenib—FGFR1—FGF signaling pathway—MMP9—Kawasaki disease	0.000548	0.00247	CbGpPWpGaD
Sorafenib—RAF1—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.000536	0.00242	CbGpPWpGaD
Sorafenib—RET—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	0.000536	0.00241	CbGpPWpGaD
Sorafenib—RAF1—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000533	0.0024	CbGpPWpGaD
Sorafenib—PDGFRB—Beta3 integrin cell surface interactions—VEGFA—Kawasaki disease	0.00053	0.00239	CbGpPWpGaD
Sorafenib—CDK7—HIV Infection—CCR5—Kawasaki disease	0.000528	0.00238	CbGpPWpGaD
Sorafenib—ABCB1—heart—Kawasaki disease	0.000519	0.00168	CbGeAlD
Sorafenib—RAF1—Focal Adhesion—BLK—Kawasaki disease	0.000509	0.00229	CbGpPWpGaD
Sorafenib—ABCG2—HIF-2-alpha transcription factor network—VEGFA—Kawasaki disease	0.000497	0.00224	CbGpPWpGaD
Sorafenib—CDK7—HIV Life Cycle—CD4—Kawasaki disease	0.00048	0.00216	CbGpPWpGaD
Sorafenib—FGFR1—Endochondral Ossification—MMP9—Kawasaki disease	0.000478	0.00215	CbGpPWpGaD
Sorafenib—MAPK11—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.000478	0.00215	CbGpPWpGaD
Sorafenib—KDR—EPH-Ephrin signaling—MMP9—Kawasaki disease	0.000478	0.00215	CbGpPWpGaD
Sorafenib—BRAF—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.000473	0.00213	CbGpPWpGaD
Sorafenib—KIT—C-MYB transcription factor network—CD4—Kawasaki disease	0.000465	0.0021	CbGpPWpGaD
Sorafenib—MAP3K7—C-MYB transcription factor network—CD4—Kawasaki disease	0.000465	0.0021	CbGpPWpGaD
Sorafenib—RAF1—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.000448	0.00202	CbGpPWpGaD
Sorafenib—MAP3K7—TCR Signaling Pathway—CD4—Kawasaki disease	0.00044	0.00198	CbGpPWpGaD
Sorafenib—FGFR1—Endochondral Ossification—VEGFA—Kawasaki disease	0.000429	0.00193	CbGpPWpGaD
Sorafenib—KDR—EPH-Ephrin signaling—VEGFA—Kawasaki disease	0.000429	0.00193	CbGpPWpGaD
Sorafenib—PDGFRB—SHP2 signaling—VEGFA—Kawasaki disease	0.000417	0.00188	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—CD40—Kawasaki disease	0.000402	0.00181	CbGpPWpGaD
Sorafenib—KDR—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000387	0.00174	CbGpPWpGaD
Sorafenib—RAF1—AGE/RAGE pathway—MMP9—Kawasaki disease	0.000374	0.00168	CbGpPWpGaD
Sorafenib—RAF1—SHP2 signaling—VEGFA—Kawasaki disease	0.000372	0.00168	CbGpPWpGaD
Sorafenib—FLT1—Focal Adhesion—VEGFA—Kawasaki disease	0.000367	0.00165	CbGpPWpGaD
Sorafenib—KDR—Signaling by VEGF—VEGFA—Kawasaki disease	0.000365	0.00164	CbGpPWpGaD
Sorafenib—PDGFRA—Allograft Rejection—VEGFA—Kawasaki disease	0.000362	0.00163	CbGpPWpGaD
Sorafenib—CDK7—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.000345	0.00156	CbGpPWpGaD
Sorafenib—ABCC4—Platelet degranulation—VEGFA—Kawasaki disease	0.000342	0.00154	CbGpPWpGaD
Sorafenib—RAF1—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.00034	0.00153	CbGpPWpGaD
Sorafenib—RAF1—TCR Signaling Pathway—CD4—Kawasaki disease	0.000335	0.00151	CbGpPWpGaD
Sorafenib—MAPK11—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000332	0.0015	CbGpPWpGaD
Sorafenib—CDK7—HIV Infection—CD4—Kawasaki disease	0.000332	0.00149	CbGpPWpGaD
Sorafenib—RAF1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.000327	0.00148	CbGpPWpGaD
Sorafenib—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.000326	0.00147	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—FCGR2A—Kawasaki disease	0.000315	0.00142	CbGpPWpGaD
Sorafenib—MAPK11—Signaling by VEGF—VEGFA—Kawasaki disease	0.000314	0.00141	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—IL10—Kawasaki disease	0.000308	0.00139	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—ITPKC—Kawasaki disease	0.000301	0.00136	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—ITPKC—Kawasaki disease	0.000301	0.00136	CbGpPWpGaD
Sorafenib—ABCG2—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000293	0.00132	CbGpPWpGaD
Sorafenib—EPHB6—Axon guidance—MMP9—Kawasaki disease	0.000291	0.00131	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—FCGR2A—Kawasaki disease	0.000284	0.00128	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—FCGR2A—Kawasaki disease	0.000284	0.00128	CbGpPWpGaD
Sorafenib—EPHA6—Axon guidance—MMP9—Kawasaki disease	0.000273	0.00123	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—FCGR2A—Kawasaki disease	0.000269	0.00121	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—FCGR2A—Kawasaki disease	0.000269	0.00121	CbGpPWpGaD
Sorafenib—KIT—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000268	0.00121	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—BLK—Kawasaki disease	0.000264	0.00119	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—BLK—Kawasaki disease	0.000264	0.00119	CbGpPWpGaD
Sorafenib—EPHB6—Axon guidance—VEGFA—Kawasaki disease	0.000261	0.00118	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—ITPKC—Kawasaki disease	0.000255	0.00115	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000254	0.00115	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000253	0.00114	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—ITPKC—Kawasaki disease	0.000253	0.00114	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—BLK—Kawasaki disease	0.000251	0.00113	CbGpPWpGaD
Sorafenib—MAP2K5—Focal Adhesion—VEGFA—Kawasaki disease	0.000251	0.00113	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—BLK—Kawasaki disease	0.00025	0.00113	CbGpPWpGaD
Sorafenib—BRAF—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.00025	0.00113	CbGpPWpGaD
Sorafenib—HTR2B—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000246	0.00111	CbGpPWpGaD
Sorafenib—EPHA6—Axon guidance—VEGFA—Kawasaki disease	0.000245	0.00111	CbGpPWpGaD
Sorafenib—KDR—Focal Adhesion—VEGFA—Kawasaki disease	0.000244	0.0011	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—FCGR2A—Kawasaki disease	0.000242	0.00109	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000228	0.00103	CbGpPWpGaD
Sorafenib—RAF1—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000228	0.00103	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—BLK—Kawasaki disease	0.000225	0.00102	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—CD40—Kawasaki disease	0.00022	0.00099	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—CD40—Kawasaki disease	0.00022	0.00099	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—FCGR2A—Kawasaki disease	0.000216	0.000972	CbGpPWpGaD
Sorafenib—RAF1—Signaling by VEGF—VEGFA—Kawasaki disease	0.000215	0.000969	CbGpPWpGaD
Sorafenib—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.00021	0.000948	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—MMP9—Kawasaki disease	0.000209	0.000942	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—CD40—Kawasaki disease	0.000209	0.00094	CbGpPWpGaD
Sorafenib—BRAF—Focal Adhesion—VEGFA—Kawasaki disease	0.000208	0.000938	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—CD40—Kawasaki disease	0.000208	0.000937	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—MMP9—Kawasaki disease	0.000207	0.000934	CbGpPWpGaD
Sorafenib—RAF1—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000204	0.000917	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—BLK—Kawasaki disease	0.000201	0.000906	CbGpPWpGaD
Sorafenib—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000198	0.000893	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—MMP9—Kawasaki disease	0.000195	0.000878	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—CD40—Kawasaki disease	0.000187	0.000844	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ITPKC—Kawasaki disease	0.000187	0.000843	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—VEGFA—Kawasaki disease	0.000186	0.000839	CbGpPWpGaD
Sorafenib—MKNK1—Disease—CCR5—Kawasaki disease	0.000184	0.000827	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—FCGR2A—Kawasaki disease	0.000183	0.000826	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ITPKC—Kawasaki disease	0.000183	0.000824	CbGpPWpGaD
Sorafenib—PDGFRA—Focal Adhesion—VEGFA—Kawasaki disease	0.000179	0.000808	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000179	0.000807	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000179	0.000804	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—BLK—Kawasaki disease	0.000178	0.000801	CbGpPWpGaD
Sorafenib—KDR—Axon guidance—MMP9—Kawasaki disease	0.000177	0.0008	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—VEGFA—Kawasaki disease	0.000175	0.000789	CbGpPWpGaD
Sorafenib—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.00017	0.000765	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.000169	0.00076	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—CD40—Kawasaki disease	0.000167	0.000753	CbGpPWpGaD
Sorafenib—KIT—Immune System—FCGR2A—Kawasaki disease	0.000165	0.000745	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—FCGR2A—Kawasaki disease	0.000165	0.000745	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—CRP—Kawasaki disease	0.000164	0.000737	CbGpPWpGaD
Sorafenib—PDGFRB—Focal Adhesion—VEGFA—Kawasaki disease	0.000162	0.000728	CbGpPWpGaD
Sorafenib—MAPK11—Cellular responses to stress—VEGFA—Kawasaki disease	0.000161	0.000727	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—BLK—Kawasaki disease	0.00016	0.000723	CbGpPWpGaD
Sorafenib—KIT—Immune System—BLK—Kawasaki disease	0.00016	0.000723	CbGpPWpGaD
Sorafenib—HTR2B—GPCR ligand binding—CCR5—Kawasaki disease	0.00016	0.000722	CbGpPWpGaD
Sorafenib—KDR—Axon guidance—VEGFA—Kawasaki disease	0.000159	0.000718	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ITPKC—Kawasaki disease	0.000158	0.000714	CbGpPWpGaD
Sorafenib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000158	0.000713	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—CCR5—Kawasaki disease	0.000158	0.000711	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—FCGR2A—Kawasaki disease	0.000157	0.000707	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—FCGR2A—Kawasaki disease	0.000156	0.000705	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—CCR5—Kawasaki disease	0.000155	0.000699	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—BLK—Kawasaki disease	0.000152	0.000686	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—BLK—Kawasaki disease	0.000152	0.000684	CbGpPWpGaD
Sorafenib—ABCC4—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000152	0.000684	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CD40—Kawasaki disease	0.000148	0.000666	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—CRP—Kawasaki disease	0.000147	0.000664	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—CRP—Kawasaki disease	0.000147	0.000664	CbGpPWpGaD
Sorafenib—RAF1—Focal Adhesion—VEGFA—Kawasaki disease	0.000144	0.000649	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000143	0.000646	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ITPKC—Kawasaki disease	0.000141	0.000637	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—FCGR2A—Kawasaki disease	0.000141	0.000635	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—CRP—Kawasaki disease	0.00014	0.000631	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—CRP—Kawasaki disease	0.00014	0.000629	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ITPKC—Kawasaki disease	0.000138	0.000622	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—VEGFA—Kawasaki disease	0.000137	0.000617	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—BLK—Kawasaki disease	0.000137	0.000616	CbGpPWpGaD
Sorafenib—KIT—Immune System—CD40—Kawasaki disease	0.000133	0.000601	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CD40—Kawasaki disease	0.000133	0.000601	CbGpPWpGaD
Sorafenib—FGFR1—Axon guidance—MMP9—Kawasaki disease	0.000131	0.000589	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ITPKC—Kawasaki disease	0.00013	0.000586	CbGpPWpGaD
Sorafenib—CDK7—Disease—CCR5—Kawasaki disease	0.000129	0.000583	CbGpPWpGaD
Sorafenib—HTR2C—GPCR ligand binding—CCR5—Kawasaki disease	0.000129	0.000582	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ITPKC—Kawasaki disease	0.000129	0.000581	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—CCR5—Kawasaki disease	0.000129	0.000579	CbGpPWpGaD
Sorafenib—RAF1—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000128	0.000575	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—MMP9—Kawasaki disease	0.000127	0.000571	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CD40—Kawasaki disease	0.000126	0.00057	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CD40—Kawasaki disease	0.000126	0.000568	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—CRP—Kawasaki disease	0.000126	0.000567	CbGpPWpGaD
Sorafenib—RAF1—Immune System—FCGR2A—Kawasaki disease	0.000126	0.000566	CbGpPWpGaD
Sorafenib—RAF1—Immune System—BLK—Kawasaki disease	0.000122	0.000549	CbGpPWpGaD
Sorafenib—FGFR1—Axon guidance—VEGFA—Kawasaki disease	0.000117	0.000528	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—CCR5—Kawasaki disease	0.000116	0.000522	CbGpPWpGaD
Sorafenib—MKNK1—Disease—CD4—Kawasaki disease	0.000115	0.00052	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—VEGFA—Kawasaki disease	0.000114	0.000512	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CD40—Kawasaki disease	0.000114	0.000512	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—CRP—Kawasaki disease	0.000112	0.000505	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—CD4—Kawasaki disease	0.00011	0.000498	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ITPKC—Kawasaki disease	0.00011	0.000497	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—MMP9—Kawasaki disease	0.000109	0.000491	CbGpPWpGaD
Sorafenib—RAF1—Axon guidance—MMP9—Kawasaki disease	0.000105	0.000471	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD40—Kawasaki disease	0.000101	0.000456	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—CD4—Kawasaki disease	9.96e-05	0.000449	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—CD4—Kawasaki disease	9.96e-05	0.000449	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—VEGFA—Kawasaki disease	9.78e-05	0.000441	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—CD4—Kawasaki disease	9.56e-05	0.000431	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—CD4—Kawasaki disease	9.56e-05	0.000431	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CRP—Kawasaki disease	9.52e-05	0.000429	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—CD4—Kawasaki disease	9.45e-05	0.000426	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—CD4—Kawasaki disease	9.43e-05	0.000425	CbGpPWpGaD
Sorafenib—RAF1—Axon guidance—VEGFA—Kawasaki disease	9.39e-05	0.000423	CbGpPWpGaD
Sorafenib—BRAF—Disease—CCR5—Kawasaki disease	9.37e-05	0.000422	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—MMP9—Kawasaki disease	9.32e-05	0.00042	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—CD4—Kawasaki disease	9.08e-05	0.000409	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—CCR5—Kawasaki disease	9.05e-05	0.000408	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—CD4—Kawasaki disease	9.05e-05	0.000408	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—MMP9—Kawasaki disease	8.62e-05	0.000389	CbGpPWpGaD
Sorafenib—KIT—Immune System—CRP—Kawasaki disease	8.59e-05	0.000387	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CRP—Kawasaki disease	8.59e-05	0.000387	CbGpPWpGaD
Sorafenib—KIT—Disease—CCR5—Kawasaki disease	8.53e-05	0.000384	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ITPKC—Kawasaki disease	8.5e-05	0.000383	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—CD4—Kawasaki disease	8.49e-05	0.000383	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—MMP9—Kawasaki disease	8.48e-05	0.000382	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—VEGFA—Kawasaki disease	8.37e-05	0.000377	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—CCR5—Kawasaki disease	8.22e-05	0.000371	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—CD4—Kawasaki disease	8.16e-05	0.000368	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CRP—Kawasaki disease	8.15e-05	0.000367	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CRP—Kawasaki disease	8.13e-05	0.000366	CbGpPWpGaD
Sorafenib—CDK7—Disease—CD4—Kawasaki disease	8.12e-05	0.000366	CbGpPWpGaD
Sorafenib—FGFR1—Disease—CCR5—Kawasaki disease	8.09e-05	0.000365	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—CCR5—Kawasaki disease	8.07e-05	0.000364	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—CCR5—Kawasaki disease	7.9e-05	0.000356	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—VEGFA—Kawasaki disease	7.82e-05	0.000352	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—VEGFA—Kawasaki disease	7.74e-05	0.000349	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—CCR5—Kawasaki disease	7.7e-05	0.000347	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—CCR5—Kawasaki disease	7.68e-05	0.000346	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—VEGFA—Kawasaki disease	7.62e-05	0.000343	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—CD4—Kawasaki disease	7.57e-05	0.000341	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—MMP9—Kawasaki disease	7.46e-05	0.000336	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CRP—Kawasaki disease	7.32e-05	0.00033	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—CCR5—Kawasaki disease	7.3e-05	0.000329	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—CCR5—Kawasaki disease	7.27e-05	0.000328	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—CD4—Kawasaki disease	7.27e-05	0.000328	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—MMP9—Kawasaki disease	7.03e-05	0.000317	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	6.76e-05	0.000305	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—VEGFA—Kawasaki disease	6.7e-05	0.000302	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—CCR5—Kawasaki disease	6.63e-05	0.000299	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—CCR5—Kawasaki disease	6.62e-05	0.000298	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—VEGFA—Kawasaki disease	6.57e-05	0.000296	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—CCR5—Kawasaki disease	6.56e-05	0.000296	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CRP—Kawasaki disease	6.53e-05	0.000294	CbGpPWpGaD
Sorafenib—RAF1—Disease—CCR5—Kawasaki disease	6.48e-05	0.000292	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CD4—Kawasaki disease	6.43e-05	0.00029	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—MMP9—Kawasaki disease	6.33e-05	0.000285	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—VEGFA—Kawasaki disease	6.31e-05	0.000284	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—CCR5—Kawasaki disease	5.97e-05	0.000269	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—CCR5—Kawasaki disease	5.97e-05	0.000269	CbGpPWpGaD
Sorafenib—BRAF—Disease—CD4—Kawasaki disease	5.88e-05	0.000265	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CD4—Kawasaki disease	5.8e-05	0.000261	CbGpPWpGaD
Sorafenib—KIT—Immune System—CD4—Kawasaki disease	5.8e-05	0.000261	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—VEGFA—Kawasaki disease	5.68e-05	0.000256	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CCR5—Kawasaki disease	5.67e-05	0.000255	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CCR5—Kawasaki disease	5.65e-05	0.000255	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CD4—Kawasaki disease	5.51e-05	0.000248	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CD4—Kawasaki disease	5.49e-05	0.000247	CbGpPWpGaD
Sorafenib—KIT—Disease—CD4—Kawasaki disease	5.36e-05	0.000241	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CCR5—Kawasaki disease	5.09e-05	0.00023	CbGpPWpGaD
Sorafenib—FGFR1—Disease—CD4—Kawasaki disease	5.08e-05	0.000229	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—CD4—Kawasaki disease	5.07e-05	0.000228	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CD4—Kawasaki disease	4.95e-05	0.000223	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CCR5—Kawasaki disease	4.86e-05	0.000219	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—CD4—Kawasaki disease	4.57e-05	0.000206	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CCR5—Kawasaki disease	4.54e-05	0.000205	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD4—Kawasaki disease	4.41e-05	0.000199	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—MMP9—Kawasaki disease	4.32e-05	0.000195	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—MMP9—Kawasaki disease	4.21e-05	0.00019	CbGpPWpGaD
Sorafenib—RAF1—Disease—CD4—Kawasaki disease	4.07e-05	0.000183	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CCR5—Kawasaki disease	3.92e-05	0.000177	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—VEGFA—Kawasaki disease	3.88e-05	0.000175	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—VEGFA—Kawasaki disease	3.78e-05	0.00017	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—MMP9—Kawasaki disease	3.62e-05	0.000163	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—MMP9—Kawasaki disease	3.59e-05	0.000162	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—MMP9—Kawasaki disease	3.27e-05	0.000147	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—MMP9—Kawasaki disease	3.27e-05	0.000147	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—VEGFA—Kawasaki disease	3.25e-05	0.000147	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—VEGFA—Kawasaki disease	3.22e-05	0.000145	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—MMP9—Kawasaki disease	3.1e-05	0.00014	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—MMP9—Kawasaki disease	3.09e-05	0.000139	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—VEGFA—Kawasaki disease	2.93e-05	0.000132	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—VEGFA—Kawasaki disease	2.93e-05	0.000132	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—MMP9—Kawasaki disease	2.79e-05	0.000126	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—VEGFA—Kawasaki disease	2.78e-05	0.000125	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—VEGFA—Kawasaki disease	2.78e-05	0.000125	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—MMP9—Kawasaki disease	2.66e-05	0.00012	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—VEGFA—Kawasaki disease	2.5e-05	0.000113	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MMP9—Kawasaki disease	2.48e-05	0.000112	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—VEGFA—Kawasaki disease	2.39e-05	0.000107	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—VEGFA—Kawasaki disease	2.23e-05	0.0001	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MMP9—Kawasaki disease	2.14e-05	9.66e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—VEGFA—Kawasaki disease	1.92e-05	8.67e-05	CbGpPWpGaD
